Plasma endothelin-1 and total insulin exposure in diabetes mellitus

Clinical Science

Volumn 97, Issue 2, 1999, Pages 149-156

  Wollesen, Flemming ^a   Berglund, Lars ^a,b   Berne, Christian ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Albumin excretion rate; Angiotensin converting enzyme inhibitor; C peptide; Diabetes mellitus; Endothelin; Glomerular filtration rate; Insulin; Insulin resistance

Indexed keywords

ALBUMIN; C PEPTIDE; CAPTOPRIL; ENDOTHELIN 1; GLIBENCLAMIDE; GLUCAGON; HEMOGLOBIN A1C; INSULIN; METFORMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FIBRINOGEN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKINFOLD THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIN-1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 0032856012     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19990008     Document Type: Article

References (51)

1. 1 Yanagisawa, M., Kurihara, H., Kimura, S. et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 332, 411-415 '
2. 2 Hoehe, M. R., Ehrenreich, H., Otterud, B. et al. (1993) The human endothelin-1 gene (EDN1) encoding a peptide with potent vasoactive properties maps distal to HLA on chromosome arm 6p in close linkage to d6s89. Cytogenet. Cell Genet. 62, 131-135
3. 3 Kohno, M., Ikeda, M., Johchi, M. et al. (1993) Interaction of PDGF and natriuretic peptides on mesangial cell proliferation and endothelin secretion. Am. J. Physiol. 265, E673-E679
4. 4 Hasdai, D., Holmes. Jr., D. R., Carrait, K. N., Edwards, W. D. and Lerman, A. (1997) Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 95, 357-362
5. 5 Nir, A., Clavell, A. L., Heublein, D., Aarhus, L. L. and Burnett, J. C. (1994) Acute hypoxia and endogenous renal endothelin. J. Am. Soc. Nephrol. 4, 1920-1924
6. 6 Wilkes, L. C., Patel, V., Purkiss, J. R. and Boarder, M. R. (1993) Endothelin-1 stimulated phospholipase-D in A10 vascular smooth muscle derived cells is dependent on tyrosine kinase. Evidence for involvement in stimulation of mitogenesis. FEBS Lett. 322, 147-150
7. 7 Yamagishi, S., Hsu, C. C., Kobayashi, K. and Yamamoto, H. (1993) Endothelin-1 mediates endothelial cell-dependent proliferation of vascular pericytes. Biochem. Biophys. Res. Commun. 191, 840-846
8. 8 Badr, K. F., Murray, J. J., Breyer, M. D., Takahashi, K., Inagami, T. and Harris, R. C. (1989) Mesangial cell, glomerular and renal vascular response to endothelin in the rat kidney. J. Clin. Invest. 83, 336-342
9. 9 Weber, H., Webb, M. L., Serafino, R. et al. (1994) Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells -evidence for common signaling mechanisms. Mol. Endocrinol. 8, 148-158
10. 10 Lerman, A., Hildeband, Jr., F. L., Aarhus, L. L. and Burnett, Jr., J. C. (1991) Endothelin has biological actions at pathophysiological concentrations. Circulation 83, 1808-1814
11. 11 Dupuis, J., Goresky, C. A. and Stewart, D. J. (1994) Pulmonary removal and production of endothelin in the anesthetized dog. J. Appl. Physiol. 76, 694-700
12. 12 Warner, T. D., Allcock, G. H. and Vane, J. R. (1994) Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ 123 and PD 145065. Br. J. Pharmacol. 112, 207-213
13. 13 Brooks, D. P., Depalma, P. D., Pullen, M. and Nambi, P. (1994) Characterization of canine renal endothelin receptor subtypes and their function. J. Pharmacol. Exp. Ther. 268, 1091-1097
14. 14 Oliver, F. J., De la Rubia, G., Feener, E. P. et al. (1991) Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J. Biol. Chem. 266, 23251-23256
15. 15 Hu, R.-M., Levin, E. R., Pedram, A. and Frank, H. J. L. (1993) Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 42, 351-358
16. 16 Hattori, Y., Kasai, K., Nakamura, T., Emoto, T. and Shimoda, S. (1991) Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 40, 165-169
17. 17 Anfossi, G., Cavalot, F., Massucco, P. et al. (1993) Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. Metabolism 42, 1081-1083
18. 18 Benatti, L., Fabbrini, M. S. and Patrono, C. (1994) Regulation of endothelin-1 biosynthesis. Ann. N. Y. Acad. Sci. 714, 109-121
19. 19 Frank, H. J. L., Levin, E. R., Hu, R.-M. and Pedram, A. (1993) Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology (Baltimore) 133, 1092-1097
20. 20 Wolpert, H. A., Steen, S. N., Istfan, N. W. and Simonson, D. C. (1993) Insulin modulates circulating endothelin-1 levels in humans. Metabolism 42, 1027-1030
21. 21 Ferri, C., Carlomagno, A., Coassin, S. et al. (1995) Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 18, 226-233
22. 22 Simonson, D. C. (1988) Etiology and prevalence of hypertension in diabetic patients. Diabetes Care 11, 821-827
23. 23 Manson, J. E., Colditz, G. A., Stampfer, M. J. et al. (1991) A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 151, 1141-1147
24. 24 Haak, T., Jungmann, E., Hillmann, U., Felber, A. and Usadel, K. H. (1993) [Significance of increased endothelin level for development of sequelae of diabetes mellitus]-Med. Klin. 88, 291-296
25. 25 Morise, T., Takeuchi, Y., Kawano, M., Koni, I. and Takeda, R. (1995) Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 18, 87-89
26. 26 Collier, A., Leach, J. P., McLellan, A., Jardine, A., Morton, J.J. and Small, M. (1992) Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 15, 1038-1040
27. 27 Kohan, D. E. (1997) Endothelins in the normal and diseased kidney. Am. J. Kidney Dis. 29, 2-26
28. 28 Zoja, C., Liu, X. H., Abbate, M. et al. (1998) Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy. Exp. Nephrol. 6, 121-131
29. 29 Turner, N. C., Morgan, P. J., Haynes, A. C., Vidgeon-Hart, M., Toseland, N. and Clapham, J. C. (1997) Elevated renal endothelin-1 clearance and mRNA levels associated with albuminuria and nephropathy in non-insulin-dependent diabetes mellitus: studies in obese fa/fa Zucker rats. Clin. Sci. 93, 565-571
30. 30 Heding, L. G. (1975) Radioimmunological determinations of human C-peptide in serum. Diabetologia 11, 541-548
31. 31 Jeppsson, J. O., Jerntorp, P., Sundkvist, G., Englund, H. and Nylund, V. (1986) Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin. Chem. 32, 1867-1872
32. 32 Tuengler, P., Metzmann, E., Pauly, H. E. and Becker, W. (1988) New immunodiagnostic systems. Behring Inst. Mitt. 82, 282-308
33. 51Cr-EDTA clearance as a measure of glomerular filtration rate. Technical note. Scand. J. Clin. Lab. Invest. 41, 611-616
34. 34 Reinken, L., Stolley, H., Droese, W. and Van Oost, G. (1979) [Longitudinal growth data of development of weight, height, skinfold thickness, head-, chest-and abdominal circumferences in healthy children]. Klin. Padiatr. 191, 556-565
35. 35 Franc, J., Dixon, W. J., Brown, M. B., Engelman, L. and Jennrich, R. I. (1990) BMDP statistical software manual, 4th edn, vol. 2, All possible subsets regression, pp. 993-1012, University of California Press, Berkeley, California
36. 36 Desideri, G., Ferri, C., Bellini, C., De Mattia, G. and Santucci, A. (1997) Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies. Diabetes 46, 81-86
37. 37 Piatti, P. M., Monti, L. D., Conti, M. et al. (1996) Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 45, 316-321
38. 38 Andronico, G., Mangano, M., Ferrara, L., Lamanna, D., Mule, G. and Cerasola, G. (1997) In vivo relationship between insulin and endothelin: role of insulin-resistance. J. Hum. Hypertens. 11, 63-66
39. 39 Ferri, C., Bellini, C., Desideri, G., De Mattia, G. and Santucci, A. (1996) Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care 19, 504-506
40. 40 Polderman, K. H., Stehouwer, C. D., van Kamp, G. J. and Gooren, L. J. (1996) Effects of insulin infusion on endothelium-derived vasoactive substances, Diabetologia 39, 1284-1292
41. 41 Leyva, F., Wingrove, C., Felton, C. and Stevenson, J. C. (1997) Physiological hyperinsulinemia is not associated with alterations in venous plasma levels of endothelin-1 in healthy individuals. Metabolism 46, 1137-1139
42. 42 Koyama, H., Nishzawa, Y., Morii, H., Tabata, T., Inoue, T. and Yamaji, T. (1989) Plasma endothelin levels in patients with uremia. Lancet i, 991-992
43. 43 Ferri, C., Bellini, C., Desideri, G. et al. (1995) Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 44, 431-436
44. 44 Ferri, C., Bellini, C., Desideri, G., Baldoncini, R., De Siati, L. and Santucci, A. (1997) Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalities. Diabetologia 40, 100-102
45. 45 Reaven, G. M. and Laws, A. (1994) Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37, 948-952
46. 46 Facchini, F., Chen, I., Hollenbeck, C. B. and Reaven, G. M. (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. J. Am. Med. Assoc. 266, 3008-3011
47. 47 Rosendorff, C. (1997) Endothelin, vascular hypertrophy, and hypertension. Gardiovasc. Drugs Ther. 10, 795-802
48. 48 Lee, Y. J., Shin, S. J. and Tsai, J. H. (1994) Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 17, 263-266
49. 49 Bertello, P., Veglio, F., Pinna, G. et al. (1994) Plasma endothelin in NIDDM patients with and without complications. Diabetes Care 17, 574-577
50. 50 Gruden, G., Cavallo Perin, P., Bazzan, M., Stella, S., Vuolo, A. and Pagano, G. (1994) PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 43, 426-429
51. 51 Vermes, I., Spooren, P. F. M. J., Kalsbeekbatenburg, E. M. and Haanen, C. (1993) In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus, Diabetologia 36, 472-473